ArticleBiotechnology letters2026
The impact of DNA methyltransferase inhibitors on carotenoid metabolism in Dunaliella salina.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Epigenetic regulation refers to heritable changes in gene expression that occur without alteration of the DNA sequence, primarily mediated by DNA methylation. In this study, we applied two DNA methyltransferase (DNMT) inhibitors, zebularine (Zeb) and 5-azacytidine (5-Azac), to alter the epigenetic landscape of Dunaliella salina and observe the resulting phenotypic changes. Long-term (40-day) treatment revealed that, on Day 40, Zeb dose-dependently increased the proportion of 9-cis β-carotene from 52.4% in the control to 82.0% at 50 μM, and further to 91.9% at 100 μM. In contrast, 5-Azac (200 μM) promoted the accumulation of α-carotenoids (α-carotene and lutein) while reducing β-carotene content. To explain these long-term metabolic shifts, we performed short-term (4-day) treatments to assess global DNA methylation and transcriptional responses of key carotenogenic genes. Unexpectedly, both DNMT inhibitors were associated with a modest increase in 5-methylcytosine levels in D. salina, contrary to the canonical expectation of demethylation. qRT-PCR revealed that 100 μM Zeb broadly upregulated carotenogenic genes, especially β-carotene isomerase (DsBCI), correlating with 9-cis enrichment. In contrast, 200 μM 5-Azac suppressed phytoene synthase (DsPSY) while upregulating lycopene ε-cyclase (DsLCYE) and β-carotene hydroxylase (DsBCH), redirecting flux toward α-carotenoids. Overall, chemical inhibition of DNA methyltransferases reprogrammed the carotenoid metabolism of D. salina. Zeb treatment markedly elevated 9-cis β-carotene levels, whereas 5-Azac promoted a relative enrichment of α-carotenoids. These findings implicate epigenetic regulation in carotenoid metabolism in D. salina and could provide a basis for future strategies aimed at the biotechnological production of high-value 9-cis β-carotene.
Indexed as
Identifiers
42704394What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.